Osteoarthritis Therapeutics Market to grow by USD 3.96 billion from 2022-2027, North America to account for 32% of market growth - Technavio

Source :: PR Newswire. January 16, 2024
Publication Year :: 2024
Abstract: NEW YORK, Jan. 16, 2024 /PRNewswire/ -- Thehttps://www.technavio.com/report/report/osteoarthritis-therapeutics-market-industry-analysis?utm_source=prnewswire&utm_medium=prnewswire&utm_campaign=T2023_VRD_wk03_2024_016_rep&utm_content=IRTNTR43212 size is expected to grow byUSD 3.96 billion from 2022 to 2027. In addition, the momentum of the market will progress at [...]

Subjects :: Bayer AG -- Forecasts and trends
Johnson & Johnson -- Forecasts and trends
Anika Therapeutics Inc. -- Forecasts and trends
GSK PLC -- Forecasts and trends
Viatris Inc. -- Forecasts and trends
Boehringer Ingelheim GmbH -- Forecasts and trends
Novartis AG -- Forecasts and trends
Horizon Therapeutics PLC -- Forecasts and trends
F. Hoffmann-La Roche Ltd. -- Forecasts and trends
Zimmer Biomet Holdings, Inc. -- Forecasts and trends
Abbott Laboratories (Abbott Park, Illinois) -- Forecasts and trends
Sanofi S.A. -- Forecasts and trends
Antiarthritic agents -- Forecasts and trends
Osteoarthritis -- Forecasts and trends
Market trend/market analysis
Business
News, opinion and commentary

Tools